Bulletin
Investor Alert

Syros Pharmaceuticals Inc.

NAS: SYRS

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Dec 5, 2022, 5:11 p.m.

/zigman2/quotes/201168308/composite

$

3.81

Change

-0.02 -0.52%

Volume

Volume 485

Quotes are delayed by 20 min

/zigman2/quotes/201168308/composite

Today's close

$ 4.00

$ 3.83

Change

-0.17 -4.25%

Day low

Day high

$3.82

$4.01

Open

52 week low

52 week high

$3.52

$43.30

Open

Annual Financials for Syros Pharmaceuticals Inc.

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue 1.1M2.05M1.98M15.09M23.49M
Cost of Goods Sold (COGS) incl. D&A 1.53M----
COGS excluding D&A -----
Depreciation & Amortization Expense 1.53M1.6M2.72M3.04M3.02M
Depreciation 1.53M1.6M2.72M3.04M3.02M
Amortization of Intangibles -----
Gross Income (426,000)----
20172018201920202021 5-year trend
SG&A Expense 54.26M64.74M77M94.36M119.89M
Research & Development 41.9M50.18M58.25M76.07M97.11M
Other SG&A 12.36M14.56M18.76M18.29M-
Other Operating Expense -----
Unusual Expense ---375,000(16.68M)
EBIT after Unusual Expense ---(82.67M)(82.74M)
Non Operating Income/Expense 676,0002.02M2.3M--
Non-Operating Interest Income ---426,00087,000
Equity in Affiliates (Pretax) -----
Interest Expense ---1.79M3.91M
Gross Interest Expense ---1.79M3.91M
Interest Capitalized -----
Pretax Income (54.01M)(62.28M)(75.44M)(84.04M)(86.56M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (54.01M)(62.28M)(75.44M)(84.04M)(86.56M)
Minority Interest Expense -----
Net Income (54.01M)(62.28M)(75.44M)(84.04M)(86.56M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (54.01M)(62.28M)(75.44M)(84.04M)(86.56M)
Preferred Dividends -----
Net Income Available to Common (54.01M)(62.28M)(75.44M)(84.04M)(86.56M)
EPS (Basic) (21.26)(19.07)(18.76)(18.25)(13.84)
Basic Shares Outstanding 2.54M3.27M4.02M4.61M6.25M
EPS (Diluted) (21.26)(19.07)(18.76)(18.25)(13.84)
Diluted Shares Outstanding 2.54M3.27M4.02M4.61M6.25M
EBITDA (53.16M)(62.69M)(75.02M)(79.26M)(96.4M)
Link to MarketWatch's Slice.